Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Harte Hanks (HHS) Restructuring Costs (2019 - 2025)

Harte Hanks (HHS) has disclosed Restructuring Costs for 4 consecutive years, with $300000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Restructuring Costs changed N/A to $300000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $1.1 million, a N/A change, with the full-year FY2024 number at $2.4 million, down 57.8% from a year prior.
  • Restructuring Costs was $300000.0 for Q4 2024 at Harte Hanks, down from $800000.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $2.2 million in Q1 2021 to a low of $300000.0 in Q4 2024.
  • A 3-year average of $1.3 million and a median of $1.4 million in 2020 define the central range for Restructuring Costs.
  • Peak YoY movement for Restructuring Costs: tumbled 69.68% in 2020, then soared 60.91% in 2021.
  • Harte Hanks' Restructuring Costs stood at $1.4 million in 2020, then grew by 7.53% to $1.5 million in 2021, then plummeted by 80.0% to $300000.0 in 2024.
  • Per Business Quant, the three most recent readings for HHS's Restructuring Costs are $300000.0 (Q4 2024), $800000.0 (Q3 2024), and $1.5 million (Q4 2021).